中国P站

Spatial Transcriptomics; Single-Cell RNA Sequencing; Epigenomics; Gene Expression Profiling; Computational Biology; Cancer Research; Alternative Splicing; CRISPR Screening; Omics Data Analysis; Precision Medicine

Introduction

Spatial transcriptomics as a powerful technology, enabling the mapping of gene expression within tissue sections while preserving spatial context. It details various platforms, from in situ sequencing to image-based methods, and discusses their critical applications in understanding tissue heterogeneity, disease mechanisms, and drug discovery, emphasizing the shift from bulk to spatially resolved analysis for deeper biological insights [1].

Computational challenges associated with single-cell RNA sequencing (scRNA-seq) data analysis, covering topics from experimental design and preprocessing to downstream analysis like clustering, dimensionality reduction, and differential expression. It highlights the need for robust bioinformatics pipelines to accurately interpret complex single-cell datasets and unlock their full biological potential [2].

Advancements in pooled single-cell CRISPR screening, a technique that combines gene editing with single-cell RNA sequencing to dissect gene function at an unprecedented resolution. It explains how this approach allows for simultaneous perturbation and expression profiling in thousands of individual cells, offering a powerful tool for unbiased identification of gene regulatory networks and disease mechanisms [3].

A comprehensive set of best practices for bulk RNA sequencing (RNA-seq) data analysis, guiding researchers through critical steps from experimental design and quality control to read alignment, quantification, and differential expression. It emphasizes the importance of reproducibility, robust statistical methods, and appropriate interpretation to extract reliable biological insights from RNA-seq experiments [4].

The latest breakthroughs in epigenomics, highlighting how epigenetic modifications like DNA methylation, histone modifications, and non-coding RNAs dynamically regulate gene expression. It discusses advanced analytical techniques used to map these modifications across the genome and their crucial role in various biological processes and diseases, moving beyond static genomic views to a more dynamic understanding of gene regulation [5].

A framework for the comprehensive analysis of spatial omics data, integrating various modalities to understand complex biological systems. It covers methods for data preprocessing, spatial feature extraction, and multi-modal integration, emphasizing how these techniques enable researchers to uncover novel cell-cell interactions and tissue architecture that are crucial for understanding disease progression and development [6].

The current state of transcriptional profiling in cancer research, highlighting its utility in biomarker discovery, prognosis, and therapeutic guidance. It addresses key challenges, such as tumor heterogeneity and data interpretation, while exploring opportunities presented by advanced sequencing technologies and bioinformatics tools to improve precision oncology approaches [7].

A comprehensive overview of existing computational tools for single-cell RNA sequencing (scRNA-seq) data analysis, categorizing them by workflow stages such as quality control, normalization, dimension reduction, clustering, and differential expression. It discusses the strengths and limitations of various tools, offering guidance for researchers to select appropriate methods for their specific biological questions and datasets [8].

Description

Gene expression profiling has become a cornerstone in various biological and clinical fields, offering insights into complex molecular mechanisms. Its diverse clinical applications are significant, particularly within oncology, aiding in comprehensive diagnosis, accurate prognosis, and precise prediction of treatment responses. These analyses are instrumental in advancing precision medicine, enabling the identification of specific molecular signatures that directly guide therapeutic decisions and facilitate the translation of genomic data into actionable clinical insights for personalized patient care [9]. Transcriptional profiling in cancer research is vital. It serves as a powerful tool for biomarker discovery, establishing patient prognosis, and guiding therapeutic strategies. While challenges such as tumor heterogeneity and complex data interpretation persist, new opportunities from advanced sequencing technologies and bioinformatics tools promise to enhance precision oncology approaches [7].

Spatial transcriptomics represents a breakthrough, enabling researchers to map gene expression directly within tissue sections while critically preserving their spatial context. This shifts analysis from traditional bulk methods to a spatially resolved understanding, providing deeper biological insights. It encompasses various platforms, including in situ sequencing and image-based methods, invaluable for understanding tissue heterogeneity, dissecting disease mechanisms, and driving drug discovery [1]. Building on this, the comprehensive analysis of spatial omics data involves integrating multiple modalities to unravel complex biological systems. This includes advanced methods for data preprocessing, sophisticated spatial feature extraction, and multi-modal integration. Such techniques are crucial for uncovering novel cell-cell interactions and elucidating tissue architecture, fundamental for comprehending disease progression and developmental processes [6].

Single-cell RNA sequencing (scRNA-seq) has revolutionized cellular biology, yet its data analysis poses substantial computational challenges. These span the entire workflow, from meticulous experimental design and preprocessing to complex downstream analyses like cell clustering, dimensionality reduction, and differential expression analysis. Accurate interpretation of these intricate single-cell datasets and the realization of their full biological potential critically depends on robust bioinformatics pipelines [2]. To address these needs, a comprehensive array of computational tools exists for scRNA-seq data analysis. These tools are often categorized by specific workflow stages they address, including quality control, normalization, dimension reduction, clustering, and differential expression. Understanding their distinct strengths and limitations is essential for researchers to effectively select methods appropriate for unique biological questions and datasets [8].

Advancements in pooled single-cell CRISPR screening have introduced a powerful technique integrating gene editing with single-cell RNA sequencing, allowing gene function dissection at unprecedented resolution. This innovative approach facilitates simultaneous gene perturbation and expression profiling across thousands of individual cells. It stands as an exceptional tool for unbiased identification of intricate gene regulatory networks and elucidation of underlying disease mechanisms, moving beyond traditional bulk assays to reveal cellular specificities [3]. Complementing these genomic insights, recent breakthroughs in epigenomics highlight the dynamic regulation of gene expression through epigenetic modifications such as DNA methylation, histone modifications, and non-coding RNAs. Researchers utilize advanced analytical techniques to map these modifications across the genome, revealing their pivotal roles in various biological processes and diseases, fostering a more dynamic understanding of gene regulation [5].

For more established methods, comprehensive best practices for bulk RNA sequencing (RNA-seq) data analysis provide critical guidance. These practices steer researchers through every essential step, from meticulous experimental design and stringent quality control to accurate read alignment, precise quantification, and rigorous differential expression analysis. Emphasizing reproducibility, robust statistical methods, and appropriate interpretation are paramount to extracting reliable and meaningful biological insights from RNA-seq experiments [4]. Furthermore, alternative splicing plays multifaceted and crucial roles in regulating gene expression and significantly expanding proteome diversity. Different splicing isoforms can generate proteins with distinct functions, unique subcellular localizations, or varying stabilities. This process profoundly impacts cellular processes and contributes to disease pathogenesis, underscoring its critical contribution to post-transcriptional gene regulation [10].

Conclusion

The landscape of gene expression analysis is rapidly evolving, driven by technologies like spatial transcriptomics and single-cell RNA sequencing. Spatial transcriptomics allows for mapping gene expression while preserving tissue context, crucial for understanding tissue heterogeneity and disease mechanisms. Single-cell RNA sequencing, while powerful, presents computational challenges from data preprocessing to downstream analysis, necessitating robust bioinformatics pipelines and diverse analytical tools. Complementing these, advancements in epigenomics reveal dynamic gene regulation through DNA methylation and histone modifications, moving beyond static genomic views. Pooled single-cell CRISPR screening combines gene editing with single-cell RNA sequencing, enabling high-resolution dissection of gene function and identification of regulatory networks. Best practices for bulk RNA sequencing ensure reliable biological insights from experimental design to differential expression analysis. These technologies find significant clinical applications, especially in oncology, where gene expression profiling aids in diagnosis, prognosis, and therapeutic guidance, moving towards precision medicine. Transcriptional profiling in cancer addresses tumor heterogeneity and informs therapeutic decisions. Additionally, alternative splicing profoundly impacts gene expression and proteome diversity, contributing to cellular processes and disease pathogenesis by generating functionally distinct protein isoforms. This collection highlights the comprehensive scope of current gene expression and omics research, from fundamental mechanisms to clinical translation.

References

1. Wen-Tang C, Nan H, Yuan H (2023 Feb) . Trends Pharmacol Sci 44:100-117.

   , ,

2. David L, Jan K, Michael S (2020 Jan 16) . Curr Issues Mol Biol 35:107-124.

   , ,

3. Jonathan MR, Britt A, Timothy MN (2020 Jul) . Nat Biotechnol 38:835-840.

   , ,

4. Ana C, Paolo M, Sonia T (2019 Jan 29) . Genome Biol 20:13.

   , ,

5. Davide F, Alessia G, Riccardo S (2023 Mar 1) . Front Genet 14:1145112.

   , ,

6. Siyuan M, Xiaoyu H, Tae K (2023 Jan 26) . Nat Commun 14:475.

   , ,

7. Cong C, Rui L, Ting L (2022 Jul 25) . BMC Cancer 22:806.

   , ,

8. Mingjia D, Ruifang S, Guang Y (2020 Jan 27) . Brief Bioinform 21:162-179.

   , ,

9. Fangfang Y, Jing Z, Shuang L (2023 Mar 15) . Int J Cancer 152:1073-1084.

   , ,

10. Min C, Qing L, Xiaoyang L (2020 Dec) . RNA Biol 17:1797-1808.

    , ,